CA Stock MarketDetailed Quotes

Aptose Biosciences Inc (APS)

Watchlist
  • 2.190
  • +0.060+2.82%
15min DelayMarket Closed Jan 15 16:00 ET
5.59MMarket Cap2.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aptose Biosciences Inc (APS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.46%4.91M
-5.77%6.92M
-44.05%5.46M
-49.85%26.26M
-81.97%2.19M
-40.37%6.97M
-49.18%7.35M
-30.76%9.76M
22.90%52.36M
16.57%12.13M
Selling and administrative expenses
19.34%2.7M
23.64%3.62M
-6.50%3.09M
-28.36%11.14M
-12.09%2.64M
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
-General and administrative expense
19.34%2.7M
23.64%3.62M
-6.50%3.09M
-28.36%11.14M
-12.09%2.64M
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
7.68%15.54M
-16.79%3M
Research and development costs
-53.11%2.21M
-25.27%3.3M
-63.32%2.36M
-58.92%15.1M
-105.01%-457K
-43.05%4.7M
-58.30%4.41M
-26.85%6.45M
30.89%36.77M
34.53%9.12M
Depreciation amortization depletion
200.00%12K
-20.00%4K
-50.00%3K
-61.22%19K
-50.00%4K
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
-Depreciation and amortization
200.00%12K
-20.00%4K
-50.00%3K
-61.22%19K
-50.00%4K
-60.00%4K
-58.33%5K
-66.67%6K
-39.51%49K
-55.56%8K
Operating profit
29.46%-4.91M
5.77%-6.92M
44.05%-5.46M
49.85%-26.26M
81.97%-2.19M
40.37%-6.97M
49.18%-7.35M
30.76%-9.76M
-22.90%-52.36M
-16.57%-12.13M
Net non-operating interest income (expenses)
-1,866.67%-212K
-218.28%-110K
-169.42%-84K
-86.97%150K
-144.44%-76K
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
Non-operating interest income
----
----
----
-68.98%357K
-23.39%131K
-94.83%12K
-71.47%93K
-71.33%121K
46.07%1.15M
-57.36%171K
Non-operating interest expense
----
--110K
--84K
--207K
----
----
----
----
--0
----
Total other finance cost
1,866.67%212K
218.28%110K
----
----
----
---12K
---93K
----
----
----
Other net income (expenses)
2K
-12K
300.00%2K
33,950.00%677K
67,700.00%678K
50.00%-1K
77.78%-2K
-50.00%1K
Gain on sale of security
--2K
---12K
300.00%2K
33,950.00%677K
67,700.00%678K
----
----
50.00%-1K
77.78%-2K
-50.00%1K
Income before tax
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
Income tax
Earnings from equity interest net of tax
Net income
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
Net income continuous operations
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
Noncontrolling interests
Net income attributable to the company
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
Diluted earnings per share
82.26%-2.01
78.75%-2.76
88.15%-2.61
84.00%-36.38
98.17%-0.7901
78.54%-11.33
80.93%-12.99
66.94%-22.02
-11.49%-227.43
11.60%-43.23
Basic earnings per share
82.26%-2.01
78.75%-2.76
88.15%-2.61
84.00%-36.38
98.17%-0.7901
78.54%-11.33
80.93%-12.99
66.94%-22.02
-11.49%-227.43
11.60%-43.23
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.46%4.91M-5.77%6.92M-44.05%5.46M-49.85%26.26M-81.97%2.19M-40.37%6.97M-49.18%7.35M-30.76%9.76M22.90%52.36M16.57%12.13M
Selling and administrative expenses 19.34%2.7M23.64%3.62M-6.50%3.09M-28.36%11.14M-12.09%2.64M-33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M
-General and administrative expense 19.34%2.7M23.64%3.62M-6.50%3.09M-28.36%11.14M-12.09%2.64M-33.85%2.26M-24.13%2.93M-37.17%3.31M7.68%15.54M-16.79%3M
Research and development costs -53.11%2.21M-25.27%3.3M-63.32%2.36M-58.92%15.1M-105.01%-457K-43.05%4.7M-58.30%4.41M-26.85%6.45M30.89%36.77M34.53%9.12M
Depreciation amortization depletion 200.00%12K-20.00%4K-50.00%3K-61.22%19K-50.00%4K-60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K
-Depreciation and amortization 200.00%12K-20.00%4K-50.00%3K-61.22%19K-50.00%4K-60.00%4K-58.33%5K-66.67%6K-39.51%49K-55.56%8K
Operating profit 29.46%-4.91M5.77%-6.92M44.05%-5.46M49.85%-26.26M81.97%-2.19M40.37%-6.97M49.18%-7.35M30.76%-9.76M-22.90%-52.36M-16.57%-12.13M
Net non-operating interest income (expenses) -1,866.67%-212K-218.28%-110K-169.42%-84K-86.97%150K-144.44%-76K-94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K
Non-operating interest income -------------68.98%357K-23.39%131K-94.83%12K-71.47%93K-71.33%121K46.07%1.15M-57.36%171K
Non-operating interest expense ------110K--84K--207K------------------0----
Total other finance cost 1,866.67%212K218.28%110K---------------12K---93K------------
Other net income (expenses) 2K-12K300.00%2K33,950.00%677K67,700.00%678K50.00%-1K77.78%-2K-50.00%1K
Gain on sale of security --2K---12K300.00%2K33,950.00%677K67,700.00%678K--------50.00%-1K77.78%-2K-50.00%1K
Income before tax 26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M
Income tax
Earnings from equity interest net of tax
Net income 26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M
Net income continuous operations 26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M
Noncontrolling interests
Net income attributable to the company 26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M
Diluted earnings per share 82.26%-2.0178.75%-2.7688.15%-2.6184.00%-36.3898.17%-0.790178.54%-11.3380.93%-12.9966.94%-22.02-11.49%-227.4311.60%-43.23
Basic earnings per share 82.26%-2.0178.75%-2.7688.15%-2.6184.00%-36.3898.17%-0.790178.54%-11.3380.93%-12.9966.94%-22.02-11.49%-227.4311.60%-43.23
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.53%
Sample Name
Sample Code
 +14.61%
Sample Name
Sample Code
 +14.50%
4
KUAISHOU-W
01024
+6.29%
5
JD HEALTH
06618
+6.26%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -